Average Insider

Where insiders trade, we follow

$TXG
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Healthcare
Sector
Medical - Healthcare Information Services
Industry
Serge Saxonov
CEO
1306
Employees
$18.39
Current Price
$2.60B
Market Cap
52W Low$6.78
Current$18.3969.2% above low, 30.8% below high
52W High$23.56

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00--All Sells
Sells46$1,005,104.9550,157
2 monthsBuys00--All Sells
Sells46$1,005,104.9550,157
3 monthsBuys00--All Sells
Sells46$1,005,104.9550,157
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Mar 2, 2026
Saxonov Serge
Director
Sale14,292$22.67$323,985.35View Details
Mar 2, 2026
Saxonov Serge
Director
Sale1,860$23.18$43,111.27View Details
Feb 25, 2026
Teichmann Sarah A.
Director
Sale7,579$19.41$147,108.39View Details
Feb 23, 2026
Saxonov Serge
Director
Sale9,632$18.58$178,927.88View Details
Feb 23, 2026
Taich Adam
Chief Financial Officer
Sale8,968$18.58$166,593.16View Details
Feb 23, 2026
Hindson Benjamin J.
Director
Sale7,826$18.58$145,378.91View Details
9 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Feb 12, 2026
EPS
Estimated-$0.19
ActualN/A
Revenue
Estimated$160.35M
ActualN/A
Feb 11, 2026
EPS
Estimated-$0.20
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Version: v26.3.23